Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue

The increase in metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH) is a worldwide healthcare challenge. Heterogeneity between men and women in the prevalence and mechanisms of MASLD and MASH is related to differential sex hormone signalling within the liver, and declining hormone levels during aging. In this study we used biochemically characterised pluripotent stem cell derived 3D liver spheres to model the protective effects of testosterone and estrogen signalling on metabolic liver disease 'in the dish'. We identified sex steroid-dependent changes in gene expression which were protective against metabolic dysfunction, fibrosis, and advanced cirrhosis patterns of gene expression, providing new insight into the pathogenesis of MASLD and MASH, and highlighting new druggable targets. Additionally, we highlight gene targets for which drugs already exist for future translational studies.

Authors

Institutions

Publication Details

Journal
Stem Cell Research & Therapy
Published
2025-03-11
DOI
https://doi.org/10.1186/s13287-025-04238-0
Citations
4
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
5.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue

David C. Hay, Philippa T. K. Saunders, Alvile Kasarinaite, Andrea Corsinotti et al.
4 citations
Stem Cell Research & Therapy
Liver Disease Diagnosis and Treatment
5.42
article

Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue

David C. Hay, Philippa T. K. Saunders, Alvile Kasarinaite, Andrea Corsinotti, Elena F. Sutherland, Meryam Beniazza, Timothy James Kendall, Maria Jiménez Ramos, Jonathan Andrew Fallowfield, Neil Cowan Henderson, Ying Chi, Mariana Beltran-Sierra, Pedro Arede Rei, Ming Zhao
article en
4 citations

Abstract

The increase in metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH) is a worldwide healthcare challenge. Heterogeneity between men and women in the prevalence and mechanisms of MASLD and MASH is related to differential sex hormone signalling within the liver, and declining hormone levels during aging. In this study we used biochemically characterised pluripotent stem cell derived 3D liver spheres to model the protective effects of testosterone and estrogen signalling on metabolic liver disease 'in the dish'. We identified sex steroid-dependent changes in gene expression which were protective against metabolic dysfunction, fibrosis, and advanced cirrhosis patterns of gene expression, providing new insight into the pathogenesis of MASLD and MASH, and highlighting new druggable targets. Additionally, we highlight gene targets for which drugs already exist for future translational studies.

Stem Cell Research & TherapyVol. 16(1)
MRC Centre for Regenerative Medicine (GB), MRC Centre for Reproductive Health (GB), Centre for Inflammation Research (GB), Zhejiang University-University of Edinburgh Institute (CN), Institute of Genetics and Cancer (GB), University of Edinburgh (GB)
Wellcome Trust, Medical Research Council, Innovate UK
Good health and well-being
Openalex Percentile: Top 5%
Liver Disease Diagnosis and Treatment
5.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.